Lung-dominant connective tissue disease clinical, radiologic, and histologic features

Chest

Volumn 148, Issue 6, 2015, Pages 1438-1446

  Omote, Norihito ^a,b   Taniguchi, Hiroyuki ^a   Kondoh, Yasuhiro ^a   Watanabe, Naohiro ^b   Sakamoto, Koji ^b   Kimura, Tomoki ^a   Kataoka, Kensuke ^a   Johkoh, Takeshi ^c   Fujimoto, Kiminori ^d   Fukuoka, Junya ^e   Otani, Kyoko ^f   Nishiyama, Osamu ^g   Hasegawa, Yoshinori ^b  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^f KOBE UNIVERSITY HOSPITAL   (Japan)

^g KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; PIRFENIDONE; RHEUMATOID FACTOR; AUTOANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG DOMINANT CONNECTIVE TISSUE DISEASE; LUNG INFILTRATE; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; THORAX RADIOGRAPHY; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASES; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; IMMUNOLOGY; JAPAN; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RADIOGRAPHY; SEROLOGY; SURVIVAL ANALYSIS;

ADULT; AGED; AUTOANTIBODIES; BIOPSY; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; JAPAN; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84948980938     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-3174     Document Type: Article

References (33)

1. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarifcation. Chest. 2010;138(2): 251-256.
2. Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-748.
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324.
4. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-1277.
5. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581-590.
6. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-347.
7. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993; 36 (3): 340-347.
8. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 1998;41(5):768-777.
9. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2): 319-338.
10. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720-735.
11. Meyer KC, Raghu G, Baughman RP, et al; American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004-1014.
12. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
13. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1994;149(6):1583-1590.
14. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164(7): 1182-1185.
15. Lee HK, Kim DS, Yo o B, et al. Histopat ho-logic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019-2027.
16. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177(4):433-439.
17. Sumikawa H, Johkoh T, Fujimoto K, et al. Pathologically proved nonspecif c interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern. Radiology. 2014;272(2):549-556.
18. Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med. 2003;167(10):1410-1415.
19. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;136(1):23-30.
20. Moua T, Zamora Martinez A, Baqir M, Vassallo R, Limper AH, Ryu JH. Predictors of diagnosis and survival in idio-pathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res. 2014;15(1): 154.
21. Kono M, Nakamura Y, Enomoto N, et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS ONE. 2014;9(4): e94775.
22. Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecif c interstitial pneumonia. Eur Respir J. 2002;19(6):1114-1118.
23. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 2000; 162 (6): 2213-2217.
24. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecif c interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1999; 160 (3): 899-905.
25. Kondoh Y, Taniguchi H, Yokoi T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005;25(3):528-533.
26. Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175(7):705-711.
27. Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380(9842):689-698.
28. King TE Jr, Bradford WZ, Castro-Bernardini S, et al; ASCEND Study Group. A phase 3 trial of pirfeni-done in patients with idiopathic pulmonary fbrosis. N Engl J Med. 2014;370(22):2083-2092.
29. Taniguchi H, Ebina M, Kondoh Y, et al; Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fbrosis. Eur Respir J. 2010;35(4):821-829.
30. Watanabe N, Sakamoto K, Taniguchi H, et al. efficacy of combined therapy with cyclosporin and low-dose prednisolone in interstitial pneumonia associated with connective tissue disease. Respiration. 2014;87(6):469-477.
31. Fischer A, Brown KK, Du Bois RM, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013;40(5):640-646.
32. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21): 1968-1977.
33. Richeldi L, du Bois RM, Raghu G, et al; INPULSIS Trial Investigators. Effcacy and safety of nintedanib in idiopathic pulmonary fbrosis. N Engl J Med. 2014;370(22):2071-2082.